Ankita Jain, MD
Addiction Medicine · Taunton, MANPI 1053845412
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 18 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 11 manufacturers, the largest accounting for just 18.1% — the pattern of someone who eats at a lot of different presentations. 2024 is the largest year on record at $406, more than ten times the $21 reported in 2022.
Across 18 payments — averaging $26.12 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$85
- AbbVie$68
- AstraZeneca$68
- Amgen$57
- Novo Nordisk$54
- Lilly USA, LLC$26
- plus $112 from 5 others
What the payments were for
- Food & beverage$470100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson(2 entities) | 2 | $85 |
| AbbVie | 2 | $68 |
| AstraZeneca | 3 | $68 |
| Amgen | 3 | $57 |
| Novo Nordisk | 2 | $54 |
| Lilly USA, LLC | 1 | $26 |
| Harmony Biosciences LLC | 1 | $24 |
| Exact Sciences | 1 | $24 |
| Grifols USA, LLC | 1 | $24 |
| Indivior Inc. | 1 | $21 |
| GSK | 1 | $18 |
How this compares
$470 in reported general payments places this provider in the 60th percentile of 57 addiction medicine providers in Massachusetts.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Pantoprazole Sodium | 12 | $345 |
| Atorvastatin Calcium | 14 | $168 |
| Amlodipine Besylate | 12 | $133 |
Paid to pharmacies, not to this prescriber.
Other addiction medicine in Taunton
- Brian OconnorWoburn$51K
- Laura KehoeAttleboro$35K
- Adam BiedReading$31K
- Kenneth FreedmanJamaica Plain$21K
- Roger WeissBelmont$11K
- Wesley KleinHyannis$6K
- Myles Jen KinWestminster$5K
- Satkiran GrewalWest Springfield$4K
- Jesus SosaFall River$3K
- Norma LopezLynnfield$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.